3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
IVD Medical Holding's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was -56.37%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for IVD Medical Holding's 3-Year ROIIC % or its related term are showing as below:
HKSE:01931's 3-Year ROIIC % is ranked worse than 84.95% of 93
companies
in the Medical Distribution industry
Industry Median: 1.14
vs HKSE:01931: -56.37
IVD Medical Holding 3-Year ROIIC % Historical Data
The historical data trend for IVD Medical Holding's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of IVD Medical Holding's 3-Year ROIIC %
For the Medical Distribution subindustry, IVD Medical Holding's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVD Medical Holding's 3-Year ROIIC % Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, IVD Medical Holding's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where IVD Medical Holding's 3-Year ROIIC % falls into.
IVD Medical Holding 3-Year ROIIC % Calculation
IVD Medical Holding's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
IVD Medical Holding (HKSE:01931) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
IVD Medical Holding 3-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of IVD Medical Holding's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
IVD Medical Holding (HKSE:01931) Business Description
IVD Medical Holding Ltd is principally engaged in the sale and manufacture of medical equipment and consumables and the provision of consultancy and maintenance services related to medical equipment. It has three segments. The distribution business, which is the key revenue driver, involves the trading of IVD analysers, reagents, and other consumables to customers such as distributors, hospitals and healthcare institutions, and logistics providers. The After-sales Services provided by Vastec include maintenance and repair services, installation services and end-customer training. Its Self-branded Products Business, distributes its self-developed IVD products under its own brand which includes IVD analysers and reagents under the IVD testing category of Point-of-care testing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01931 has been successfully added to your 